Preclinical Activity of Embryonic Annexin A2-Specific Chimeric Antigen Receptor T Cells Against Ovarian Cancer

Chimeric antigen receptors (CARs) have found clinical success in B cell malignancies, but a dearth of potential targets limits their wider clinical application, especially in solid tumours. Here, we describe the development of an anti-annexin A2 CAR, CAR(2448), derived from an antibody found to have...

Descripción completa

Detalles Bibliográficos
Autores principales: Leong, Leonard, Tan, Heng Liang, Cua, Simeon, Yong, Kylie Su Mei, Chen, Qingfeng, Choo, Andre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013580/
https://www.ncbi.nlm.nih.gov/pubmed/31936170
http://dx.doi.org/10.3390/ijms21020381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013580/
https://www.ncbi.nlm.nih.gov/pubmed/31936170
http://dx.doi.org/10.3390/ijms21020381

Ejemplares similares